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Abstract
Introduction: Thermal destruction mediated by radiofrequency ablation (RFA) is gaining attention
as an alternative treatment for patients with renal cell carcinoma (RCC), particularly in those who
are not candidates for open surgery. Treatment of central tumours is occasionally associated with
complications such as ureteric stricture, injury to the psoas muscle, haematuria and vascular
laceration.
Case presentation: We have used infusion of cold saline during RFA, through a retrograde
ureteric catheter with its tip in the renal pelvis, in a patient with a central renal tumour.
Conclusion: We believe this process to have successfully avoided the risk of thermal injury.
Introduction
Thermal destruction mediated by radiofrequency ablation
(RFA) is gaining attention as an alternative treatment for
patients with renal cell carcinoma (RCC), particularly in
those who are not candidates for open surgery [1]. RFA
carries less risk in the treatment of peripheral RCC. Treat-
ment of centrally located tumours is occasionally associ-
ated with complications such as ureteric stricture, injury
to the psoas muscle, haematuria and vascular laceration
[2]. However, protective measures can be taken to increase
the safety of RFA when the electrode is located near the
hilum of the kidney. We have used infusion of cold saline
during RFA, through a retrograde ureteric catheter with its
tip in the renal pelvis, in a patient with a central renal
tumour in order to reduce the risk of thermal injury.
Case presentation
A 62-year-old woman who had an incidental finding on
computed tomography (CT) of a right renal mass was
referred to our unit for RFA. The CT appearance of the
tumor, which 3.2 × 3.2 × 3.8 cm, were consistent with (but
not diagnostic of) primary RCC. Its medial margin was
immediately adjacent to the renal pelvis (Fig 1). At the
time of diagnosis the left kidney was atrophic. There was
no evidence of metastases. The patient had been previ-
ously evaluated by a urologist expert in partial nephrec-
tomy. However, given the size and location of the mass,
and the fact that the contra-lateral kidney was atrophic,
surgery was considered inappropriate following discus-
sion at two consecutive multidisciplinary meetings at the
referring hospital. The alternative of RFA with simultane-
ous cold saline irrigation of the renal pelvis was discussed
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at multidisciplinary meetings at both the referring hospi-
tal and our own institution and informed consent was
obtained from the patient.
Prior to the RFA procedure, a 4.8 F retrograde ureteric
catheter was inserted under endoscopic guidance and its
tip advanced to the right renal pelvis (Fig 2). A Foley 14 F
urethral catheter was inserted in the bladder and attached
to a drainage bag. This system was used to irrigate the
renal pelvis with cold saline (0.9%) at a rate of 1 l/hour.
The irrigation was started 60 minutes before the proce-
dure with saline at normal temperature and continued
during the procedure with ice-cold saline. Subsequently
the patient was transferred to the CT suite and unen-
hanced computed tomography images of the tumor were
obtained. Following intravenous sedation and analgesia
with 6 mg midazolam and 100 μg fentanyl, and infiltra-
tion of the percutaneous track with local anaesthetic
(lidocaine 1%), a 20 G cutting needle was used to obtain
a biopsy. Subsequently, a single 10 cm radiofrequency
electrode (CoolTip, Radionics, Burlingthon, Mass) was
placed into the tumor and used to ablate two adjacent
areas for 12 minutes each. The temperatures reached 79°C
and 82°C. The minimum distance of the electrode from
the renal pelvis was 16 mm and 14 mm respectively. The
total amount of normal and low temperature saline used
during this procedure was 2.3 litres. The fluid emerging
from the bladder catheter remained clear throughout the
procedure. The ureteric and the Foley catheters were
removed 30 minutes after the end of the procedure. A CT
examination 24 hours later showed coagulation of the
tumor and no evidence of hydronephrosis (Fig 3). The
renal biopsy result demonstrated an oncocytoma. Follow-
up CT at six months shows no evidence of recurrent
tumour or hydronephrosis.
Discussion
Asymptomatic renal tumours are being demonstrated
with increasing frequency [3,4]. Although partial nephrec-
tomy is the standard therapy for small RCC [2], minimally
invasive options associated with limited morbidity–such
as probe-ablative procedures–are, however, being investi-
gated in selected patients for whom invasive, nephron-
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sparing surgery (whether laparoscopic or open) is unde-
sirable. The main probe-ablative techniques being investi-
gated as alternatives to partial nephrectomy are
cryoablation, radiofrequency ablation, and high-intensity
focused ultrasound. Advances in imaging, ablative system
technologies, and early evidence that in situ tumor abla-
tion can yield comparable results to those achieved with
tumor resection in selected cases, have sparked significant
interest in these minimally invasive techniques.
RFA is an increasingly employed alternative treatment
option, especially in patients with significant co-morbidi-
ties or those who refuse surgery [1]. RFA of peripheral
renal tumours is effective in achieving coagulation in
most cases, because the kidneys are surrounded by fat,
which prevents heat loss from the area being treated. In
the case of central tumours, well-perfused tissue, vessels
and the fluid-filled collecting system are found near the
treatment area, potentially diminishing effectiveness and
increasing the risk of complications. Ahrar et al. [5]
reported four major complications, three of them in
patients with solitary kidneys and central renal tumors.
Additional procedures were necessary in these patients,
such as insertion of a ureteric stent to deal with obstruc-
tion of the renal system by blood clot. Other complica-
tions associated with ablation of central renal tumors
include injury, to the lumbar plexus, ureteral stricture,
injury to psoas muscle and vascular laceration.
The treatment of renal lesions is complicated by heat loss,
both conductive and convective. The kidney has a high
blood flow, leading to substantial convective heat loss
during renal RFA [2]. Some authors have managed to
increase ablation diameters by reducing blood flow to the
treated area using embolization or clamping of the renal
artery [6]. The use and efficacy of generators of 200 W or
greater and careful technique is helpful in achieving a sat-
isfactory result [2].
As a new modality treatment of renal tumors, contra-indi-
cations to renal RFA are in evolution and are related with
tumor in immediate proximity to a hollow viscus, renal
pelvis or ureter. These contra-indications can be
attempted to be reduced by the use of simultaneous irriga-
tion with cold saline via ureteric catheter into the renal
pelvis prior and during the ablation and in doing so,
major complications may be avoided. This in keeping
with previous reports were cooling systems were used to
avoid complications of adjacent tissues in different
organs. Dominique et al. [7] reported the feasibility of
treating liver tumours close to a main biliary duct using
intraductal cooling during RFA avoiding heat-induce
damage and stenosis of biliary ducts. Similarly, Hiraki et
al.[8]. published the use of RFA of metastatic mediastinal
lymph nodes during cooling and temperature monitoring
of the tracheal mucosa to prevent thermal damage. RFA
with retrograde saline irrigation of centrally located renal
parenchymal lesions had been proved safe and efficient in
animal studies by Margulis et al.[9], which concluded that
retrograde renal cooling helps protect the renal collecting
system from injury during RFA without a decrease in
expected lesion size. They also suggested that clinically
retrograde renal cooling may decrease the risk of collect-
ing system injury and subsequent complications during
RFA. RFA with cooling system had been now reported in
humans with the use of either normal saline or dextrose
without significant differences in between them. [10,11]
Conclusion
Although in our patient the biopsy revealed an Oncocy-
toma, it does not make any difference regarding the pro-
cedure itself as the lesion was close to the renal pelvis. We
believe that using the ureteral irrigation catheter system
we were able to prevent heat damage, either gross haema-
turia or ureteral stricture, as well as it may improve the
impedance guarantying better ablation. This technique
might be considered while performing RFA of central
renal masses in order to avoid complications. It will be
important for further evaluation of this technique in large
clinical case series.
Editor's note
Peer review was divided on the merits of this manuscript,
and importantly also on the safety of using cold Saline
rather than Dextrose. This is an area of clinical controversy
and we urge readers to remember that this is only a single
case report and that clinical decision making should
always be based on the best available evidence.
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Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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